FoundMyFitness #064 Dr. Michael Snyder on Continuous Glucose Monitoring and Deep Profiling for Personalized Medicine
20 snips
May 27, 2021 Dr. Michael Snyder, Director of the Center for Genomics and Personalized Medicine at Stanford, dives into the power of continuous glucose monitoring and deep profiling. He shares how smartwatches can help diagnose conditions like Lyme disease and the role of personal health data in predicting illnesses. The conversation highlights the significance of personalized dietary choices and exercise for longevity, alongside insights on how environmental factors shape our health through the concept of the exposome. Tune in for a fascinating look at leveraging data for better health outcomes!
AI Snips
Chapters
Transcript
Episode notes
Diabetes Discovery
- Dr. Snyder's genome sequencing revealed a predisposition to type 2 diabetes, despite his healthy lifestyle.
- Regular blood sugar monitoring, prompted by this discovery, led to an early diagnosis after a viral infection.
Prediabetes Prevalence
- 90% of prediabetics are unaware of their condition.
- Early detection through continuous glucose monitoring is crucial for preventing progression to full-blown diabetes.
Personalized Food Responses
- Different foods cause varying blood glucose spikes in individuals, partly due to the gut microbiome.
- Continuous glucose monitors (CGMs) help identify personal trigger foods for better dietary control.